Skip to main content
Premium Trial:

Request an Annual Quote

Gene Logic Licenses Cardiovascular Data Suite to Artesian

NEW YORK, March 14 - Gene Logic on Thursday said that Artesian Therapeutics has subscribed to its GeneExpress cardiovascular data suite.

The privately held biopharmaceutical company will use the database as a "primary reference source" in its cardiovascular drug-discovery and -development efforts.

Financial details of the multiyear deal were not disclosed.


According to Gene Logic, its cardiovascular data suite contains samples of a variety of cardiac and vascular diseases. The company added that "over time" it hopes to include in vitro and in vivo animal models.

The Scan

Y Chromosome Study Reveals Details on Timing of Human Settlement in Americas

A Y chromosome-based analysis suggests South America may have first been settled more than 18,000 years ago, according to a new PLOS One study.

New Insights Into TP53-Driven Cancer

Researchers examine in Nature how TP53 mutations arise and spark tumor development.

Mapping Single-Cell Genomic, Transcriptomic Landscapes of Colorectal Cancer

In Genome Medicine, researchers present a map of single-cell genomic and transcriptomic landscapes of primary and metastatic colorectal cancer.

Expanded Genetic Testing Uncovers Hereditary Cancer Risk in Significant Subset of Cancer Patients

In Genome Medicine, researchers found pathogenic or likely pathogenic hereditary cancer risk variants in close to 17 percent of the 17,523 patients profiled with expanded germline genetic testing.